Johnson & Johnson has placed its global media buying and planning account into review.
The incumbent on the media account in APAC is OMD. According to a statement given to Adage the media review cuts across the company’s consumer, pharmaceutical and medical-device businesses and brands.
The article also quotes a spokesperson at Johnson & Johnson saying that the company is “working towards its goal to have the best media capability in strategy, planning and buying against evolved business strategies and marketing frameworks for Johnson & Johnson’s business sectors and brands around the world.”
Most recently, Johnson & Johnson announced its plans to file for regulatory approval of more than ten of its new products between 2015 and 2019, each with the potential to exceed US$1 billion in revenue. In 2014, the company’s worldwide sales increased 4.2% to US$74.3 billion, compared to increases of 6.1% in 2013 and 3.4% in 2012.
Marketing has reached out to Johnson & Johnson Singapore for a confirmation.